PHENERGAN VC
LOE Approachingphenylephrine hydrochloride; promethazine hydrochloride
NDAORALSYRUP
Approved
Sep 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PHENERGAN VC is an oral syrup combination of phenylephrine hydrochloride (a decongestant) and promethazine hydrochloride (a first-generation antihistamine and antiemetic). It is indicated for symptomatic relief of upper respiratory congestion, allergic rhinitis, and nausea associated with colds and allergies. The product works by reducing nasal congestion via alpha-adrenergic stimulation while providing antihistamine and anti-nausea effects.
LOE Approaching
This legacy product approaches loss of exclusivity with moderate competitive pressure (30/100), signaling a smaller, maintenance-focused team focused on generic defense and market stabilization rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PHENERGAN VC offers limited growth trajectory but valuable experience in legacy product stewardship, generic defense, and portfolio optimization in a mature market. Roles focus on operational excellence, cost management, and market stabilization rather than innovation or team expansion.
Brand Manager (Specialty/Legacy)Field Sales Representative
Worked on PHENERGAN VC at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.